AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AFT Pharmaceuticals anticipates announcing a $2 million operating loss for the first half of 2024 due to reduced international and Asian sales, influenced by factors like a South Korean doctors strike. Despite these setbacks, the company reports double-digit growth in Australia and New Zealand and remains optimistic about a sales recovery in the second half of the financial year. AFT remains well-capitalized and is exploring initiatives to improve its full-year forecast.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue